ANTIOXIDANTS AND REPERFUSION INJURY IN AGING HEART
衰老心脏中的抗氧化剂和再灌注损伤
基本信息
- 批准号:6098816
- 负责人:
- 金额:$ 0.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-03-20 至 1999-07-31
- 项目状态:已结题
- 来源:
- 关键词:age difference aging animal old age antioxidants cardiolipins electrospray ionization mass spectrometry gas chromatography hemodynamics high performance liquid chromatography juvenile animal laboratory rat lipid metabolism metabolism disorder mitochondria myocardial ischemia /hypoxia myocardium nonhuman therapy evaluation oxidative stress perfusion reperfusion sulfur aminoacid
项目摘要
The morbidity and mortality of acute myocardial infarction remains
dramatically elevated in elderly patients despite successful reperfusion
treatments. The functional recovery of ischemic-reperfused tissue is
impaired in elderly patients. We utilized Fischer 344 rat model of aging
to study the increased injury present in the aging heart. Tissue damage
was increased, and hemodynamic recovery decreased, in isolated buffer
perfused hearts from 24 month elderly rats compared to 6 month adult
controls. Elderly rats have a preexisting aging-related decrease in
complex III and cytochrome oxidase activities that are selective to the
interfibrillar population of cardiac mitochondria (IFM). Ischemia caused
damage to complex III in IFM that was superimposed upon the aging defect.
We propose that the baseline aging defects present in IFM act in concert
with superimposed ischemic damage to augment oxidative injury during
reperfusion, and that increased oxidative damage contributes to the excess
injury observed in the aging heart. Oxidative reactions with mitochondrial
membrane lipids will deplete cardiolipin, a phospholipid highly enriched
in polyunsaturated acyl-residues, and alter the composition of cardiolipin
as a signature of oxidative injury. To investigate the contributions of
oxidative mechanisms to the excess injury that occurs during ischemia and
reperfusion in the aging heart, we will determine if treatment with cell-
permeable antioxidants such as N-2-mercaptopropionylglycine will
ameliorate the excess damage observed in the aging heart during
reperfusion. The targets of oxidative reperfusion injury in the aging
heart in mitochondria will be assessed by measuring specific endpoints of
oxidative damage including the depletion and oxidative alteration of
cardiolipin. The decreased tolerance of the aging heart to ischemia and
reperfusion represent a novel situation in which to explore the
contributions of aging-related metabolic defects acting in concert with
the superimposed metabolic stress of ischemia to further impair recovery
of the aging heart. This experimental approach will delineate the targets
of oxidative injury during ischemia and reperfusion in the aging heart and
contribute to the design of mechanism-based adjunctive treatment
strategies to enhance outcome in the high-risk elderly patient suffering
from acute myocardial infarction.
急性心肌梗死的发病率和死亡率仍居高不下
尽管成功再灌注,老年患者的血压仍显着升高
治疗。缺血再灌注组织的功能恢复是
老年患者受损。我们利用 Fischer 344 大鼠衰老模型
研究衰老心脏中存在的增加的损伤。组织损伤
在隔离缓冲液中增加,血流动力学恢复降低
24 个月龄老年大鼠与 6 个月成年大鼠的灌注心脏
控制。老年大鼠先前存在与衰老相关的
复合体 III 和细胞色素氧化酶活性对
心脏线粒体(IFM)的纤维间群体。缺血引起
IFM 中复合物 III 的损伤叠加在老化缺陷上。
我们建议 IFM 中存在的基线老化缺陷协同作用
叠加缺血性损伤以增强氧化损伤
再灌注,氧化损伤的增加导致过度
在衰老的心脏中观察到的损伤。与线粒体的氧化反应
膜脂会消耗心磷脂(一种高度浓缩的磷脂)
多不饱和酰基残基,并改变心磷脂的组成
作为氧化损伤的标志。调查贡献
缺血期间发生的过度损伤的氧化机制
老化心脏的再灌注,我们将确定是否使用细胞治疗
渗透性抗氧化剂,例如 N-2-巯基丙酰甘氨酸
改善老化心脏在老化过程中观察到的过度损伤
再灌注。衰老过程中氧化再灌注损伤的靶点
线粒体中的心脏将通过测量特定终点来评估
氧化损伤,包括消耗和氧化改变
心磷脂。衰老的心脏对缺血的耐受力下降
再灌注代表了一种新的情况,在这种情况下探索
与衰老相关的代谢缺陷协同作用的贡献
缺血叠加的代谢应激进一步损害恢复
属于衰老的心脏。这种实验方法将描绘目标
衰老心脏缺血和再灌注过程中氧化损伤的影响
有助于设计基于机制的辅助治疗
提高高危老年患者治疗效果的策略
来自急性心肌梗塞。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Edward J Lesnefsky其他文献
Edward J Lesnefsky的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Edward J Lesnefsky', 18)}}的其他基金
Metformin Therapy for Ischemic Insult and Reperfusion Injury in Aging
二甲双胍治疗衰老缺血性损伤和再灌注损伤
- 批准号:
10846164 - 财政年份:2021
- 资助金额:
$ 0.23万 - 项目类别:
Metformin Therapy for Ischemic Insult and Reperfusion Injury in Aging
二甲双胍治疗衰老缺血性损伤和再灌注损伤
- 批准号:
10298194 - 财政年份:2021
- 资助金额:
$ 0.23万 - 项目类别:
Metformin Therapy for Ischemic Insult and Reperfusion Injury in Aging
二甲双胍治疗衰老缺血性损伤和再灌注损伤
- 批准号:
10475290 - 财政年份:2021
- 资助金额:
$ 0.23万 - 项目类别:
Reduction of cardiac injury by targeting damaged mitochondria during reperfusion
通过针对再灌注期间受损的线粒体来减少心脏损伤
- 批准号:
8698292 - 财政年份:2012
- 资助金额:
$ 0.23万 - 项目类别:
Reduction of cardiac injury by targeting damaged mitochondria during reperfusion
通过针对再灌注期间受损的线粒体来减少心脏损伤
- 批准号:
8457978 - 财政年份:2012
- 资助金额:
$ 0.23万 - 项目类别:
Reduction of cardiac injury by targeting damaged mitochondria during reperfusion
通过针对再灌注期间受损的线粒体来减少心脏损伤
- 批准号:
8795682 - 财政年份:2012
- 资助金额:
$ 0.23万 - 项目类别:
Reduction of cardiac injury by targeting damaged mitochondria during reperfusion
通过针对再灌注期间受损的线粒体来减少心脏损伤
- 批准号:
8333547 - 财政年份:2012
- 资助金额:
$ 0.23万 - 项目类别:
Mitochondrial Dysfunction in the Aged Heart: Role of Endoplasmic Reticulum Stress
老年心脏线粒体功能障碍:内质网应激的作用
- 批准号:
10513314 - 财政年份:2012
- 资助金额:
$ 0.23万 - 项目类别:
Mitochondrial Dysfunction in the Aged Heart: Role of Endoplasmic Reticulum Stress
老年心脏线粒体功能障碍:内质网应激的作用
- 批准号:
10254899 - 财政年份:2012
- 资助金额:
$ 0.23万 - 项目类别:
Myocardial Infarction in the Aging Heart: Ischemia-Damaged Mitochondria, Reticulum Stress and the Transition to Heart Failure
衰老心脏中的心肌梗死:缺血损伤的线粒体、网状应激和向心力衰竭的转变
- 批准号:
9239811 - 财政年份:2012
- 资助金额:
$ 0.23万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 0.23万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 0.23万 - 项目类别:
Collaborative R&D
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 0.23万 - 项目类别:
Operating Grants
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 0.23万 - 项目类别:
Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 0.23万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 0.23万 - 项目类别:
Studentship
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 0.23万 - 项目类别:
Fellowship Award
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 0.23万 - 项目类别:
Standard Grant
McGill-MOBILHUB: Mobilization Hub for Knowledge, Education, and Artificial Intelligence/Deep Learning on Brain Health and Cognitive Impairment in Aging.
McGill-MOBILHUB:脑健康和衰老认知障碍的知识、教育和人工智能/深度学习动员中心。
- 批准号:
498278 - 财政年份:2024
- 资助金额:
$ 0.23万 - 项目类别:
Operating Grants
Welfare Enhancing Fiscal and Monetary Policies for Aging Societies
促进老龄化社会福利的财政和货币政策
- 批准号:
24K04938 - 财政年份:2024
- 资助金额:
$ 0.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




